Drug Database
Back to search

France· FR:68601502

CILOXADEX 3 mg/1 mg par mL, suspension pour instillation auriculaire

A medicinal product containing dexaméthasone + chlorhydrate de ciprofloxacine, registered in France by INFECTOPHARM ARZNEIMITTEL UND CONSILIUM (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCILOXADEX 3 mg/1 mg par mL, suspensio…ATC—REGISTER NO.FR:68601502PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dexaméthasone + chlorhydrate de ciprofloxacineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DEXAMÉTHASONE + CHLORHYDRATE DE CIPROFLOXACINE
Manufacturer
INFECTOPHARM ARZNEIMITTEL UND CONSILIUM (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400922439716
    1 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 5 ml
    EUR 2.8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexaméthasone + chlorhydrate de ciprofloxacine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexaméthasone + chlorhydrate de ciprofloxacine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Ciprofloxacin/Dexamethasone Rafarm
  • Germany · Cilodex
  • Denmark · Cilodex
  • United Kingdom (Northern Ireland) · Ciprofloxacin/Dexamethasone Aspire Pharma, Ciprofloxacin/Dexamethasone Infectopharm
  • Greece · Ciprofloxacin+dexamethasone Rafarm
  • Italy · Cilodex, Nisegal
  • Portugal · Otifix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9d901305-6832-42b1-b2da-76e83c8a4eea
GET /v1/drugs/9d901305-6832-42b1-b2da-76e83c8a4eea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68601502",
  "date_amm": "2012-12-14",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "DEXAMÉTHASONE + CHLORHYDRATE DE CIPROFLOXACINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suspension pour instillation",
  "voies_administration": "auriculaire",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about dexaméthasone + chlorhydrate de ciprofloxacine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console